Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Ibio Inc (IBIO)

1.45   -0.06 (-3.97%) 01-21 00:48
Open: 1.52 Pre. Close: 1.51
High: 1.5231 Low: 1.41
Volume: 7,738,020 Market Cap: 313M
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. The company is headquartered in New York City, New York and currently employs 7 full-time employees. The firm is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. Its technologies include iBioLaunch technology and iBioModulator. The firm's technologies constitute a transformative platform for development and production of biologics in hydroponically grown green plants. The firm is focused on the commercialization of its plant-based protein expression technologies for vaccines and therapeutic proteins and on developing and commercializing select biopharmaceutical product candidates. The firm's technology is applicable in a range of product candidates, including products against fibrotic diseases, vaccines, enzyme replacements, monoclonal antibodies, and recombinant versions of marketed products that are derived from human blood plasma.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.524 - 1.531 1.531 - 1.537
Low: 1.39 - 1.4 1.4 - 1.408
Close: 1.436 - 1.451 1.451 - 1.463

Technical analysis

as of: 2021-01-20 4:48:28 PM
Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 2.18     One year: 2.55
Support: Support1: 1.35    Support2: 1.03
Resistance: Resistance1: 1.87    Resistance2: 2.18
Pivot: 1.30
Moving Average: MA(5): 1.48     MA(20): 1.27
MA(100): 1.70     MA(250): 1.73
MACD: MACD(12,26): 0.04     Signal(9): -0.01
Stochastic oscillator: %K(14,3): 53.17     %D(3): 54.63
RSI: RSI(14): 55.86
52-week: High: 7.45  Low: 0.23  Change(%): 367.7
Average Vol(K): 3-Month: 1181327  10-Days: 1799518

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
IBIO has closed below upper band by 28.1%. Bollinger Bands are 29.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 18 Jan 2021
COVID 19 Impact On Plant-Based Vaccines Market Outlook with Top Industry: Medicago, Inc., iBio, Inc., and Icon Genetics- GmbH - The Courier

Wed, 13 Jan 2021
Ibio Shares Bounce Back Strongly: Should You Buy? - Own Snap

Wed, 13 Jan 2021
Premarket Mover: Ibio Inc (IBIO) Up 18.99% - InvestorsObserver

Tue, 12 Jan 2021
How Will the Market React to Ibio Inc (IBIO) Stock Getting a Bullish Rating - InvestorsObserver

Sun, 10 Jan 2021
Is Ibio (IBIO) A Better Coronavirus Stock Bet For 2021? – Own Snap - Own Snap

Thu, 07 Jan 2021
iBio's (NYSEMKT:IBIO) Wonderful 324% Share Price Increase Shows How Capitalism Can Build Wealth - Simply Wall St

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 174
Shares Float (M) 117
% Held by Insiders 8.78
% Held by Institutions 11.56
Shares Short (K) 20,000
Shares Short P. Month (K) 7,300

Stock Financials

EPS -0.975
EPS Est This Year -0.150
EPS Est Next Year -0.200
Book Value (p.s.) 0.040
Profit Margin
Operating Margin -1138.46
Return on Assets (ttm) -24.0
Return on Equity (ttm) -320.6
Qtrly Rev. Growth -81.8
Gross Profit (p.s.) 0.012
Sales Per Share 0.008
EBITDA (p.s.) -0.074
Qtrly Earnings Growth
Operating Cash Flow (M) -14
Levered Free Cash Flow (M) -8

Stock Valuations

PE Ratio -1.49
PEG Ratio
Price to Book value 36.25
Price to Sales 193.06
Price to Cash Flow -18.23

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.